Inhibition of caspase-3 by S-nitrosation and oxidation caused by nitric oxide

被引:191
作者
Mohr, S
Zech, B
Lapetina, EG
Brune, B
机构
[1] UNIV ERLANGEN NURNBERG, FAC MED, DEPT MED 4, EXPT DIV, D-91054 ERLANGEN, GERMANY
[2] CASE WESTERN RESERVE UNIV, MOL CARDIOVASC RES CTR, SCH MED, CLEVELAND, OH 44106 USA
关键词
D O I
10.1006/bbrc.1997.7304
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Apoptotic signaling cascades converge in the activation of caspases (interleukin-1 beta converting enzyme like proteases). Treatment of the human promyelocytic leukaemia cell line U937 with actinomycin D resulted in the activation of caspase-3 also known as CPP32. Protease activity was measured in cytosolic extracts by fluorometric analysis of the time-dependent cleavage of acetyl-Asp-Glu-Val-Asp-aminomethylcoumarin (DEVD-AMC), a caspase-3 substrate. Caspase activity was inhibited by thiol modifying agents such as N-ethylmaleimide or iodoacetamide and NO donors such as S-nitrosoglutathione (GSNO), BF4NO, and spermine-ETO. NO-mediated enzyme inhibition was fully reversible upon the addition of DTT (dithiothreitol). NO. itself was not primarily responsible for downregulation of caspase-3, as we found no correlation between rates of NO. release and the magnitude of enzyme inhibition. It is likely that S-nitrosation accounts for enzyme inhibition by various NO donors. SIN-1 and peroxynitrite were inhibitory as well. In this case, however, enzyme activity was not restored upon DTT addition, suggesting oxidation as an additional thiol modification mechanism. Our studies provide evidence that caspases are targeted by NO via S-nitrosation and oxidation of critical thiol groups. (C) 1997 Academic Press.
引用
收藏
页码:387 / 391
页数:5
相关论文
共 32 条
  • [1] Human ICE/CED-3 protease nomenclature
    Alnemri, ES
    Livingston, DJ
    Nicholson, DW
    Salvesen, G
    Thornberry, NA
    Wong, WW
    Yuan, JY
    [J]. CELL, 1996, 87 (02) : 171 - 171
  • [2] Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424
  • [3] Suppression of apoptosis by nitric oxide via inhibition of interleukin-1 beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases
    Dimmeler, S
    Haendeler, J
    Nehls, M
    Zeiher, AM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (04) : 601 - 607
  • [4] Feelisch M., 1996, METHODS NITRIC OXIDE, P455
  • [5] SPLENIC B-LYMPHOCYTE PROGRAMMED CELL-DEATH IS PREVENTED BY NITRIC-OXIDE RELEASE THROUGH MECHANISMS INVOLVING SUSTAINED BCL-2 LEVELS
    GENARO, AM
    HORTELANO, S
    ALVAREZ, A
    MARTINEZA, C
    BOSCA, L
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (04) : 1884 - 1890
  • [7] Nitrosative stress: Activation of the transcription factor OxyR
    Hausladen, A
    Privalle, CT
    Keng, T
    DeAngelo, J
    Stamler, JS
    [J]. CELL, 1996, 86 (05) : 719 - 729
  • [8] Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-alpha-induced apoptosis by inducing heat shock protein 70 expression
    Kim, YM
    deVera, ME
    Watkins, SC
    Billiar, TR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (02) : 1402 - 1411
  • [9] NITRIC-OXIDE PRODUCED BY HUMAN B-LYMPHOCYTES INHIBITS APOPTOSIS AND EPSTEIN-BARR-VIRUS REACTIVATION
    MANNICK, JB
    ASANO, K
    IZUMI, K
    KIEFF, E
    STAMLER, JS
    [J]. CELL, 1994, 79 (07) : 1137 - 1146
  • [10] NITRIC-OXIDE SYNTHASE - ASPECTS CONCERNING STRUCTURE AND CATALYSIS
    MARLETTA, MA
    [J]. CELL, 1994, 78 (06) : 927 - 930